Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study

E. R. Gaynor, J. M. Unger, T. P. Miller, T. M. Grogan, Jr White, G. M. Mills, S. P. Balcerzak, M. Varterasian, M. LeBlanc, R. I. Fisher

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences